Expression of 5-lipoxygenase and leukotriene A4 hydrolase in human atherosclerotic lesions correlates with symptoms of plaque instability.
暂无分享,去创建一个
Anders Gabrielsen | Chi-Huey Wong | Bengt Samuelsson | Jesper Swedenborg | Jesper Z Haeggström | A. Gabrielsen | Chi‐Huey Wong | J. Haeggström | U. Hedin | B. Samuelsson | A. Wetterholm | G. Paulsson-Berne | G. Hansson | H. Agardh | J. Swedenborg | Ulf Hedin | Min Wan | M. Wan | H. Qiu | Gabrielle Paulsson-Berne | Göran K Hansson | Hong Qiu | Anders Wetterholm | Hanna E Agardh | Hanna E. Agardh
[1] Takao Shimizu,et al. A G-protein-coupled receptor for leukotriene B4 that mediates chemotaxis , 1997, Nature.
[2] T. Cohnert,et al. Expanding expression of the 5-lipoxygenase pathway within the arterial wall during human atherogenesis , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[3] Jilly F. Evans,et al. The 5-lipoxygenase pathway promotes pathogenesis of hyperlipidemia-dependent aortic aneurysm , 2004, Nature Medicine.
[4] J. Haeggström. Leukotriene A4 Hydrolase/Aminopeptidase, the Gatekeeper of Chemotactic Leukotriene B4 Biosynthesis* , 2004, Journal of Biological Chemistry.
[5] C. Funk. Leukotriene modifiers as potential therapeutics for cardiovascular disease , 2005, Nature Reviews Drug Discovery.
[6] A. Lusis,et al. Identification of 5-Lipoxygenase as a Major Gene Contributing to Atherosclerosis Susceptibility in Mice , 2002, Circulation research.
[7] Arachidonate 5-lipoxygenase promoter genotype, dietary arachidonic acid, and atherosclerosis. , 2004 .
[8] G. Hansson,et al. Electrocardiographic characterization of stress-induced myocardial infarction in atherosclerotic mice. , 2005, Acta physiologica Scandinavica.
[9] I. Ollmann,et al. PROBING THE ACTIVITIES AND MECHANISMS OF LEUKOTRIENE A4 HYDROLASE WITH SYNTHETIC INHIBITORS , 1998 .
[10] Takao Shimizu,et al. A second leukotriene B(4) receptor, BLT2. A new therapeutic target in inflammation and immunological disorders. , 2000, The Journal of experimental medicine.
[11] R. de Caterina,et al. Leukotriene B4 production in human atherosclerotic plaques. , 1988, Biomedica biochimica acta.
[12] G. Hansson,et al. Leukotriene B4 signaling through NF-kappaB-dependent BLT1 receptors on vascular smooth muscle cells in atherosclerosis and intimal hyperplasia. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[13] J. Suttles,et al. Role of Leukotriene B4 Receptors in the Development of Atherosclerosis: Potential Mechanisms , 2004, Arteriosclerosis, thrombosis, and vascular biology.
[14] H. Showell,et al. Leukotriene B4 Receptor Antagonism Reduces Monocytic Foam Cells in Mice , 2002, Arteriosclerosis, thrombosis, and vascular biology.
[15] Jilly F. Evans,et al. Characterization of the human cysteinyl leukotriene CysLT1 receptor , 1999, Nature.
[16] Jesse D. Roberts,et al. Inhibition of Atherogenesis in BLT1-Deficient Mice Reveals a Role for LTB4 and BLT1 in Smooth Muscle Cell Recruitment , 2005, Circulation.
[17] F. Cipollone,et al. Association Between 5-Lipoxygenase Expression and Plaque Instability in Humans , 2005, Arteriosclerosis, thrombosis, and vascular biology.
[18] K. Austen,et al. Leukotriene C4 synthase: a pivotal enzyme in cellular biosynthesis of the cysteinyl leukotrienes. , 2002, Prostaglandins & other lipid mediators.
[19] John Savill,et al. Resolution of inflammation: the beginning programs the end , 2005, Nature Immunology.
[20] T. Hla. Prostaglandins & other lipid mediators: a new phase, a new team. , 2004, Prostaglandins & other lipid mediators.
[21] Vilmundur Gudnason,et al. A variant of the gene encoding leukotriene A4 hydrolase confers ethnicity-specific risk of myocardial infarction , 2006, Nature Genetics.
[22] B. Samuelsson. Leukotrienes: mediators of immediate hypersensitivity reactions and inflammation. , 1983, Science.
[23] Jilly F. Evans,et al. Characterization of the Human Cysteinyl Leukotriene 2 Receptor* , 2000, The Journal of Biological Chemistry.
[24] G. Hansson. Inflammation, atherosclerosis, and coronary artery disease. , 2005, The New England journal of medicine.
[25] J. Gulcher,et al. The gene encoding 5-lipoxygenase activating protein confers risk of myocardial infarction and stroke , 2004, Nature Genetics.
[26] Aloke V. Finn,et al. Atherosclerotic Plaque Progression and Vulnerability to Rupture: Angiogenesis as a Source of Intraplaque Hemorrhage , 2005, Arteriosclerosis, thrombosis, and vascular biology.
[27] D. Steinberg,et al. Gene expression in macrophage-rich human atherosclerotic lesions. 15-lipoxygenase and acetyl low density lipoprotein receptor messenger RNA colocalize with oxidation specific lipid-protein adducts. , 1991, The Journal of clinical investigation.